Novo Nordisk readies trial results for next-generation weight-loss drug
The headline trial results will be closely monitored by pharmaceutical industry experts. Shares in Novo Nordisk, which ...
LDS Church’s huge investment portfolio hits a five-year high. See how much.
New federal reports value a massive investment portfolio of stocks, bonds and mutual funds managed on behalf of The Church of ...
Medpage Today on MSN22h
Tirzepatide Officially Puts GLP-1 Meds on the Map for Obesity-Related Heart Failure
CHICAGO -- A long-acting GIP/GLP-1 receptor agonist conferred significant clinical benefit for people with obesity and ...
If You Bought 1 Share of Eli Lilly in 1984, Here's How Many Shares You Would Own Now
The drugmaker Ely Lilly ( LLY -4.93%) has had a very successful run over the long run. Shares currently trade around $818 and are up 20,030% over the past 40 years. The stock has also performed well ...
Eli Lilly and Novo Want to Shake off Ozempic Copycats. Are They Ready to Meet Demand?
But for diabetes and obesity drugs like Ozempic and Zepbound, known as GLP-1s, cheaper copycats emerged almost ...
The UK thinks weight loss drugs could ease unemployment. Experts say that’s a fantasy
In the United Kingdom, the government is hoping weight loss drugs might improve public finances, eyeing their use to help ...
Drugmaker Stocks Slide as Trump Taps Vaccine Skeptic RFK Jr for US Health Job
(Reuters) -Shares in European vaccine makers fell on Friday after U.S. President-elect Donald Trump picked Robert F. Kennedy ...
ABC612h
Brown Loses To Holy Cross, Kino Lilly Jr Breaks Program Three Pointer Record
Kino Lilly Jr. became the program leader for most three-pointers made as the Brown men’s basketball team fell to Holy Cross, ...
Brown hosts Sacred Heart following Lilly's 24-point game
BOTTOM LINE: Brown plays Sacred Heart after Kino Lilly Jr. scored 24 points in Brown’s 73-65 loss to the Holy Cross Crusaders. Brown finished 13-18 overall last season while going 5-7 at home. The ...